Literature DB >> 9520949

Elevated c-Src protein expression is an early event in colonic neoplasia.

S Iravani1, W Mao, L Fu, R Karl, T Yeatman, R Jove, D Coppola.   

Abstract

The molecular events regulating the development and progression of colonic neoplasia are currently being delineated. Recent studies have implicated c-Src protein kinase activation as an early event in the malignant transformation of colonic epithelial cells. However, increased c-Src activity has also been reported in colon carcinomas as well as in metastatic hepatic and extrahepatic colon carcinomas. To further investigate the potential role of c-Src in the progression of colonic neoplasia, we analyzed c-Src levels by immunohistochemistry in 27 colorectal resection specimens. Mouse monoclonal antibody to c-Src protein was applied to 3-micron sections from formalin-fixed, paraffin-embedded tissues using the avidin-biotin-peroxidase method. The combination of adenomatous (AD) and adjacent carcinomatous mucosa (CA) specimens were present in 20 of 27 patients. In 15 cases, synchronous metastatic (MT) lesions were available for evaluation. Strong c-Src expression was evident in 95% of AD (n = 20), in contradistinction to 32% of MT (n = 19) and 14% of CA (n = 22). Weak-to-moderate c-Src expression was seen in adjacent normal colonic mucosa (NM) in 96% of cases. Signed rank test univariate analysis revealed a statistically significant difference in c-Src expression between NM/AD (p = 0.0001), NM/CA (p = 0.0001), NM/MT (p = 0.0006), AD/CA (p = 0.0001), and AD/MT (p = 0.0002). No significant correlation between levels of c-Src expression and patient survival, tumor size, histologic grade, or tumor configuration was observed using the Cox's Regression Model. Similar results were obtained by analysis of c-Src protein levels and c-Src kinase activity as measured by Western blot and in vitro kinase assays of representative cases. Our results indicate that: (a) elevated c-Src expression is an important early event during colorectal carcinogenesis; (b) its activation may be involved in tumor progression in a subset of colonic carcinomas; and (c) additional molecular events are necessary for invasion to occur.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9520949

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  13 in total

1.  Src tyrosine kinase phosphorylation of nuclear receptor HNF4α correlates with isoform-specific loss of HNF4α in human colon cancer.

Authors:  Karthikeyani Chellappa; Lucy Jankova; Jake M Schnabl; Songqin Pan; Yann Brelivet; Caroline L-S Fung; Charles Chan; Owen F Dent; Stephen J Clarke; Graham R Robertson; Frances M Sladek
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  c-src activating mutation analysis in Chinese patients with colorectal cancer.

Authors:  Ye-Xiong Tan; Han-Tao Wang; Peng Zhang; Zhong-Hua Yan; Guan-Long Dai; Meng-Chao Wu; Hong-Yang Wang
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

3.  Quantification of beta-catenin signaling components in colon cancer cell lines, tissue sections, and microdissected tumor cells using reaction monitoring mass spectrometry.

Authors:  Yi Chen; Mike Gruidl; Elizabeth Remily-Wood; Richard Z Liu; Steven Eschrich; Mark Lloyd; Aejaz Nasir; Marilyn M Bui; Emina Huang; David Shibata; Timothy Yeatman; John M Koomen
Journal:  J Proteome Res       Date:  2010-08-06       Impact factor: 4.466

4.  Decreased Srcasm expression in esophageal squamous cell carcinoma in a Chinese population.

Authors:  Yu Qi; Xin Li; Liang Zhao; John T Seykora
Journal:  Anticancer Res       Date:  2010-09       Impact factor: 2.480

5.  Expression and clinical significance of focal adhesion kinase in the two distinct histological types, intestinal and diffuse, of human gastric adenocarcinoma.

Authors:  Constantinos T Giaginis; Stephanie Vgenopoulou; Gerasimos S Tsourouflis; Ekaterini N Politi; Gregorios P Kouraklis; Stamatios E Theocharis
Journal:  Pathol Oncol Res       Date:  2008-11-06       Impact factor: 3.201

6.  Increases in c-Yes expression level and activity promote motility but not proliferation of human colorectal carcinoma cells.

Authors:  Jane Barraclough; Cassandra Hodgkinson; Alison Hogg; Caroline Dive; Arkadiusz Welman
Journal:  Neoplasia       Date:  2007-09       Impact factor: 5.715

7.  Phosphorylation of the SRC epithelial substrate Trask is tightly regulated in normal epithelia but widespread in many human epithelial cancers.

Authors:  Ching Hang Wong; Frederick L Baehner; Danislav S Spassov; Deepika Ahuja; Donghui Wang; Byron Hann; Jimmy Blair; Kevan Shokat; Alana L Welm; Mark M Moasser
Journal:  Clin Cancer Res       Date:  2009-03-24       Impact factor: 12.531

8.  Oncogenic signaling by tyrosine kinases of the SRC family in advanced colorectal cancer.

Authors:  Audrey Sirvent; Christine Benistant; Serge Roche
Journal:  Am J Cancer Res       Date:  2012-06-28       Impact factor: 6.166

9.  Coexpression of IGF-1R and c-Src proteins in human pancreatic ductal adenocarcinoma.

Authors:  Ardeshir Hakam; Quan Fang; Richard Karl; Domenico Coppola
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

10.  Role of cancer microenvironment in metastasis: focus on colon cancer.

Authors:  Stéphanie Gout; Jacques Huot
Journal:  Cancer Microenviron       Date:  2008-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.